Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBNNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.356NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.462NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.147NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.6 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.5 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.4 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.420NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.39.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.233NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.320NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.635NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.19 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.15 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.113NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.21 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.619.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.260NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.456NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.16 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.374NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.63 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.377NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.298NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used